Department of Cancer Biology, Oncology Institute, Cardinal Bernardin Cancer Center, Loyola University Medical Center, Maywood, IL, 60153, USA.
Departments of Molecular/Cellular Physiology and Department of Biology, Loyola University Medical Center and Loyola University Chicago, Chicago, IL, 60660, USA.
J Hematol Oncol. 2020 Nov 23;13(1):157. doi: 10.1186/s13045-020-00994-z.
Aging drives the genetic and epigenetic changes that result in a decline in hematopoietic stem cell (HSC) functioning. Such changes lead to aging-related hematopoietic/immune impairments and hematopoietic disorders. Understanding how such changes are initiated and how they progress will help in the development of medications that could improve the quality life for the elderly and to treat and possibly prevent aging-related hematopoietic diseases. Here, we review the most recent advances in research into HSC aging and discuss the role of HSC-intrinsic events, as well as those that relate to the aging bone marrow niche microenvironment in the overall processes of HSC aging. In addition, we discuss the potential mechanisms by which HSC aging is regulated.
衰老导致遗传和表观遗传变化,从而导致造血干细胞 (HSC) 功能下降。这些变化导致与衰老相关的造血/免疫损伤和造血障碍。了解这些变化是如何开始的以及它们是如何进展的,将有助于开发可以改善老年人生活质量的药物,并治疗和可能预防与衰老相关的血液疾病。在这里,我们回顾了 HSC 衰老研究的最新进展,并讨论了 HSC 内在事件的作用,以及与衰老骨髓龛微环境在 HSC 衰老的整体过程中的关系。此外,我们还讨论了 HSC 衰老的潜在调节机制。